Two The presence of hereditary BRCA1 gene mutations in women with familial breast or ovarian cancer

Outcome of five years of accelerated surveillance in patients at high risk for inherited breast/ovarian cancer

Breast-feeding and the risk of breast cancer in BRCA1 and BRCA2

A new scoring system for the chances of identifying a BRCA1/2 mutation

Two Percent of Men with Early-Onset Prostate Cancer Harbor Germline Mutations in the BRCA2 Gene

BRCA1 and BRCA2 Germline Mutations in Lymphoma Patients

Fallopian Tube and Primary Peritoneal Carcinomas Associated With BRCA Mutations

Cancer Incidence in BRCA1 Mutation Carriers

Cancer Risk Estimates for BRCA1 Mutation Carriers Identified in a Risk Evaluation Program

BRCA2 Gene Mutations in Families With Aggregations of Breast and Stomach Cancers

The genetic attributable risk of breast and ovarian cancer

The Risk of Cancer Associated with Specific Mutations of BRCA1 and BRCA2 among Ashkenazi Jews

Frequency of BRCA1 and BRCA2 Mutations in Unselected Ashkenazi Jewish Patients With Colorectal Cancer

BRCA1 and BRCA2 Founder Mutations and the Risk of Colorectal Cancer

BRCA Mutations and Risk of Prostate Cancer in Ashkenazi Jews

Impact of Germline Brca1 Mutations and Overexpression of P53 on Prognosis and Response to Treatment Following Breast Carcinoma: 10-Year Follow-Up Data

Improved Survival in Women with BRCA-Associated Ovarian Carcinoma

BRCA1 Functions as a Differential Modulator of Chemotherapy-Induced Apoptosis

Effect of BRCA Mutations on the Length of Survival in Epithelial Ovarian Tumors

Outcome of Conservatively Managed Early-Onset Breast Cancer by Brca1/2 Status

Survival In Prospectively Ascertained Familial Breast Cancer: Analysis of a Series Stratified By Tumour Characteristics, Brca Mutations and Oophorectomy

A Genetic Epidemiological Study of Carcinoma of the Fallopian Tube

Risk of Endometrial Carcinoma Associated with BRCA Mutation

Clinical Characteristics of Individuals With Germline Mutations in BRCA1 and BRCA2: Analysis of 10,000 Individuals

A combined analysis of outcome following breast cancer: differences in survival based on BRCA1/BRCA2 mutation status and administration of adjuvant treatment

Cancer Risks in BRCA2 Mutation Carriers

Variation in Cancer Risks, by Mutation Position, in BRCA2 Mutation Carriers

Genetic Heterogeneity and Penetrance Analysis of the BRCA1 and BRCA2 Genes in Breast Cancer Families

Breast Cancer Risk Assessment Models: Applicability to African-American women

Ovarian Cancer Risk in Ashkenazi Jewish Carriers of BRCA1 and BRCA2 Mutations

Average Risks of Breast and Ovarian Cancer Associated with BRCA1 or BRCA2 Mutations Detected in Case Series Unselected for Family History: A Combined Analysis of 22 Studies

The Lifetime Risks of Breast Cancer in Ashkenazi Jewish Carriers of BRCA1 and BRCA2 Mutations

Modification of BRCA1- and BRCA2: Associated Breast Cancer Risk by AIB1 Genotypeand Reproductive History

On the Use of Familial Aggregation in Population-Based Case Probands for Calculating Penetrance

The Effectiveness of the Gail Model in Estimating Risk for Development of Breast Cancer in women under 40 years of age

Understanding Mathematical Models for Breast Cancer Risk Assessment and Counseling

Limitations of the Gail Model in the Specialized Breast Cancer Risk Assessment Clinic

BRCA2 Mutation Carriers, Reproductive Factors and Breast Cancer Risk

Breast and Ovarian Cancer Risks Due to Inherited Mutations in BRCA1 and BRCA2

Effect of Radiotherapy After Breast-Conserving Treatment in Women With Breast Cancer and Germline BRCA1/2 Mutations

Prevalence of BRCA1 and BRCA2 germline mutations in young breast cancer patients: A population-based study

Long-Term Psychological Impact of Carrying a BRCA1/2 Mutation and Prophylactic Surgery: A 5-Year Follow-Up Study

Reproductive Factors and Ovarian Cancer Risk in Jewish BRCA1 And BRCA2 Mutation Carriers (United States)

Oral Contraceptives and the Risk of Hereditary Ovarian Cancer

Tamoxifen for Prevention of Breast Cancer: Report of the National Surgical Adjuvant Breast and Bowel Project P-1 Study

Tamoxifen and Risk of Contralateral Breast Cancer in BRCA1 And BRCA2 Mutation Carriers: A Case-Control Study

Smoking and the risk of breast cancer among carriers of BRCA mutations

Breast-feeding and the Risk of Breast Cancer in BRCA1 and BRCA2 Mutation Carriers

TGFBR1*6A and Cancer Risk: A Meta-Analysis of Seven Case-Control Studies

Life Insurance and Breast Cancer risk Assessment: Adverse Selection, Genetic Testing Decisions, and Discrimination

Preempting Genetic Discrimination and Assaults on Privacy: Report of a Symposium

Low-Penetrance Susceptibility to Breast Cancer Due to CHEK2*1100delC in Noncarriers of BRCA1 or BRCA2 Mutations

A CHEK2 Genetic Variant Contributing to a Substantial Fraction of Familial Breast Cancer

Frequency of CHEK2*1100delC in New York Breast Cancer Cases and Controls

Psychosocial Predictors of BRCA Counseling and Testing Decisions among Urban African-American Women

What Do Ratings of Cancer-Specific Distress Mean Among Women at High Risk of Breast and Ovarian Cancer?

Breast cancer genetics in African Americans

Tamoxifen and Breast Cancer Incidence Among Women With Inherited Mutations in BRCA1 and BRCA2

Bilateral Prophylactic Mastectomy Reduces Breast Cancer Risk in BRCA1 and BRCA2 Mutation Carriers: The PROSE Study Group

Hormone Replacement Therapy and Life Expectancy After Prophylactic Oophorectomy in Women With Mutations: A Decision Analysis

Outcome of Preventive Surgery and Screening for Breast and Ovarian Cancer in BRCA Mutation Carriers

Effect of Prevention Strategies on Survival and Quality-Adjusted Survival of Women With BRCA1/2 Mutations: An Updated Decision Analysis

Genetic testing for a BRCA1 mutation: Prophylactic Surgery and Screening behavior in women 2 years post testing

Reoperations after prophylactic mastectomy with or without implant reconstruction

Effectiveness of Modena Surveillance Program for Women at Risk For Breast Cancer

Using Sonography to Screen Women with Mammographically Dense Breasts

MRI of Occult Breast Carcinoma in a High-Risk Population

American Cancer Society Guidelines for Breast Cancer Screening: Update 2003

Cancer Genetics Network Ovarian Screening Study: Physician Practice Patterns in Screening Women at High Risk for Ovarian Cancer

A Gonadotropin-Releasing Hormone Agonist (Gnrha)-Based Chemoprevention Regimen That Reduces Mammographic Density in Brca Carriers While Maintaining Good Quality of Life (Qol), Bone Density, and Reproductive Options

Efficacy of Bilateral Prophylactic Mastectomy in Women with a Family History of Breast Cancer

Breast Cancer after Prophylactic Bilateral Mastectomy in Women with a BRCA1 or BRCA2 Mutation

Effect of Fenretinide on Ovarian Carcinoma Occurrence

Oral Contraceptives and the Risk of Breast Cancer in BRCA1 and BRCA2 Mutation Carriers

Effects of Tamoxifen on Benign Breast Disease in Women at High Risk for Breast Cancer

Prophylactic Oophorectomy in Carriers of BRCA1 or BRCA2 Mutations

Risk-Reducing Salpingo-oophorectomy in Women with a BRCA1 or BRCA2 Mutation

Life Expectancy Gains From Cancer Prevention Strategies for Women With Breast Cancer and BRCA1 or BRCA2 Mutations

Tubal Ligation and Risk of Ovarian Cancer in Carriers of Brca1 or BRCA2 Mutations: A Case-Control Study

Efficacy of bilateral prophylactic mastectomy in BRCA1 and BRCA2 gene mutation carriers

Did you know? Until recently breast cancer topped the list of leading causes of cancer deaths in women, but lately lung cancer has claimed the top position.